Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art

PURPOSE OF REVIEW: We aim to summarize the current state of art about the possible use of biomarkers for predicting renal cell carcinoma (RCC) recurrence after curative treatment. In addition, we aim to provide a snapshot about the clinical implication of biomarkers use for follow-up planification....

Descripción completa

Detalles Bibliográficos
Autores principales: Marchioni, Michele, Rivas, Juan Gomez, Autran, Anamaria, Socarras, Moises, Albisinni, Simone, Ferro, Matteo, Schips, Luigi, Scarpa, Roberto Mario, Papalia, Rocco, Esperto, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Kidney Diseases (G Ciancio, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062344/
https://www.ncbi.nlm.nih.gov/pubmed/33886004
http://dx.doi.org/10.1007/s11934-021-01050-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062344/
https://www.ncbi.nlm.nih.gov/pubmed/33886004
http://dx.doi.org/10.1007/s11934-021-01050-0

Ejemplares similares